Quintiles Transnational Holdings Inc (Q) : Accident Compensation Corp scooped up 52,981 additional shares in Quintiles Transnational Holdings Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 11, 2016. The investment management firm now holds a total of 107,481 shares of Quintiles Transnational Holdings Inc which is valued at $7.1 Million.Quintiles Transnational Holdings Inc makes up approximately 1.95% of Accident Compensation Corp’s portfolio.
Other Hedge Funds, Including , Mufg Americas Holdings Corp boosted its stake in Q in the latest quarter, The investment management firm added 11,612 additional shares and now holds a total of 13,959 shares of Quintiles Transnational Holdings Inc which is valued at $917,665. Quintiles Transnational Holdings Inc makes up approx 0.03% of Mufg Americas Holdings Corp’s portfolio. Bruderman Asset Management added Q to its portfolio by purchasing 120 company shares during the most recent quarter which is valued at $7,889.Shamrock Asset Management reduced its stake in Q by selling 273 shares or 53.11% in the most recent quarter. The Hedge Fund company now holds 241 shares of Q which is valued at $15,896. Quintiles Transnational Holdings Inc makes up approx 0.01% of Shamrock Asset Management’s portfolio.Russell Frank Co boosted its stake in Q in the latest quarter, The investment management firm added 454 additional shares and now holds a total of 85,038 shares of Quintiles Transnational Holdings Inc which is valued at $5.9 Million. Quintiles Transnational Holdings Inc makes up approx 0.01% of Russell Frank Co’s portfolio.
Quintiles Transnational Holdings Inc closed down -0.16 points or -0.24% at $65.58 with 7,36,166 shares getting traded on Monday. Post opening the session at $65.75, the shares hit an intraday low of $65.37 and an intraday high of $66.04 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Quintiles Transnational Holdings Inc reported $0.89 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on May 3, 2016. Analyst had a consensus of $0.86. The company had revenue of $1108.00 million for the quarter, compared to analysts expectations of $1118.63 million. The company’s revenue was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.72 EPS.
Many Wall Street Analysts have commented on Quintiles Transnational Holdings Inc. Quintiles Transnational Holdings Inc was Downgraded by Wells Fargo to ” Market Perform” on May 12, 2016. Shares were Downgraded by Robert W. Baird on May 4, 2016 to ” Neutral” and Lowered the Price Target to $ 74 from a previous price target of $76 .Quintiles Transnational Holdings Inc was Downgraded by Citigroup to ” Neutral” on May 4, 2016.
Quintiles Transnational Holdings Inc. is a biopharmaceutical services company. The Company is a provider of biopharmaceutical development services and commercial outsourcing services. The Company is engaged in the development and commercialization of pharmaceutical therapies. It also offers therapeutic scientific and analytical services to its biopharmaceutical and other healthcare customers. The Company offers its services through two segments: Product Development and Integrated Healthcare Services. Its product development segment is a contract research organization (CRO) and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. Its Integrated Healthcare Services segment provides services including commercial services such as contract pharmaceutical sales forces and healthcare business services such as phase research market access and consulting and health information analytics and technology consulting.